検索
Kodiak Sciences Inc
KODウォッチリストに追加
41.580USD
-0.920-2.16%
終値 07-31 16:00（ET）15分遅れの株価
2.60B時価総額
損失額直近12ヶ月PER
詳細情報 Kodiak Sciences Inc 企業名
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab tedromer, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy and wet age-related macular degeneration. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate designed to inhibit interleukin-6 (IL-6)-mediated inflammation and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Kodiak Sciences Incの企業情報
企業コードKOD
会社名Kodiak Sciences Inc
上場日Oct 04, 2018
最高経営責任者「CEO」Perlroth (Victor)
従業員数109
証券種類Ordinary Share
決算期末Oct 04
本社所在地1250 Page Mill Rd
都市PALO ALTO
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号94304
電話番号16502810850
ウェブサイトhttps://kodiak.com/
企業コードKOD
上場日Oct 04, 2018
最高経営責任者「CEO」Perlroth (Victor)
Kodiak Sciences Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John A. Borgeson
Mr. John A. Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Chief Financial Officer, Executive Vice President, Secretary
211.93K
--
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Independent Director
Independent Director
25.95K
--
Mr. Robert A. Profusek, J.D.
Mr. Robert A. Profusek, J.D.
Lead Independent Director
Lead Independent Director
10.00K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
1.00K
--
Dr. Victor Perlroth, M.D.
Dr. Victor Perlroth, M.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Felix J. Baker, Ph.D.
Dr. Felix J. Baker, Ph.D.
Independent Director
Independent Director
--
--
Dr. Bassil I. Dahiyat, Ph.D.
Dr. Bassil I. Dahiyat, Ph.D.
Independent Director
Independent Director
--
--
Dr. Taiyin Yang, Ph.D.
Dr. Taiyin Yang, Ph.D.
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John A. Borgeson
Mr. John A. Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Chief Financial Officer, Executive Vice President, Secretary
211.93K
--
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Independent Director
Independent Director
25.95K
--
Mr. Robert A. Profusek, J.D.
Mr. Robert A. Profusek, J.D.
Lead Independent Director
Lead Independent Director
10.00K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
1.00K
--
Dr. Victor Perlroth, M.D.
Dr. Victor Perlroth, M.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Felix J. Baker, Ph.D.
Dr. Felix J. Baker, Ph.D.
Independent Director
Independent Director
--
--
よくある質問
Kodiak Sciences Incの上位5名の株主は誰ですか？
Kodiak Sciences Incの上位5名の株主は以下のとおりです。Mr. John A. Borgeson
Kodiak Sciences Inc（KOD）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Kodiak Sciences Incの株式を保有している機関は311社あり、保有株式の総市場価値は約60.04Mで、全体の96.04%を占めています。2025Q4と比較して、機関の持ち株は7956993.00増加しています。